BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21954516)

  • 21. Skin-lightening practice among women living in Jordan: prevalence, determinants, and user's awareness.
    Hamed SH; Tayyem R; Nimer N; Alkhatib HS
    Int J Dermatol; 2010 Apr; 49(4):414-20. PubMed ID: 20465697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin lightening and its complications among African people living in Paris.
    Petit A; Cohen-Ludmann C; Clevenbergh P; Bergmann JF; Dubertret L
    J Am Acad Dermatol; 2006 Nov; 55(5):873-8. PubMed ID: 17052496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin lightening products' violations in Europe: An analysis of the rapid alert system for dangerous non-food products 2005-2018.
    Michalek IM; Liu B; Benn EKT; Caetano Dos Santos FL
    Regul Toxicol Pharmacol; 2019 Aug; 106():50-54. PubMed ID: 31029853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The widespread use of skin lightening creams in Senegal: a persistent public health problem in West Africa.
    del Giudice P; Yves P
    Int J Dermatol; 2002 Feb; 41(2):69-72. PubMed ID: 11982639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fairness via formulations: a review of cosmetic skin-lightening ingredients.
    Kamakshi R
    J Cosmet Sci; 2012; 63(1):43-54. PubMed ID: 22487451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of skin lightening creams. Survey in a UK general practice.
    Sidhu SK; Pau N; Sidhu JS; Oakeshott P
    BMJ; 2011 Mar; 342():d1326. PubMed ID: 21363856
    [No Abstract]   [Full Text] [Related]  

  • 28. Misuse of Topical Corticosteroids for Cosmetic Purpose in Antananarivo, Madagascar.
    Sendrasoa FA; Ranaivo IM; Andrianarison M; Raharolahy O; Razanakoto NH; Ramarozatovo LS; Rapelanoro Rabenja F
    Biomed Res Int; 2017; 2017():9637083. PubMed ID: 28904977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercury content in skin-lightening creams and potential hazards to the health of Saudi Women.
    al-Saleh I; al-Doush I
    J Toxicol Environ Health; 1997 Jun; 51(2):123-30. PubMed ID: 9176553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal change disease following exposure to mercury-containing skin lightening cream.
    Tang HL; Chu KH; Mak YF; Lee W; Cheuk A; Yim KF; Fung KS; Chan HW; Tong KL
    Hong Kong Med J; 2006 Aug; 12(4):316-8. PubMed ID: 16912361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cosmetic skin lightening use and side effects.
    Masub N; Khachemoune A
    J Dermatolog Treat; 2022 May; 33(3):1287-1292. PubMed ID: 33135510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical management of chronic mercury intoxication secondary to skin lightening products: A proposed algorithm.
    Ramli FF
    Bosn J Basic Med Sci; 2021 Jun; 21(3):261-269. PubMed ID: 32415819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin lightening practices: an epidemiological study of South African women of African and Indian ancestries.
    Dlova NC; Hamed SH; Tsoka-Gwegweni J; Grobler A
    Br J Dermatol; 2015 Jul; 173 Suppl 2():2-9. PubMed ID: 26207658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk assessment of skin lightening cosmetics containing hydroquinone.
    Matsumoto M; Todo H; Akiyama T; Hirata-Koizumi M; Sugibayashi K; Ikarashi Y; Ono A; Hirose A; Yokoyama K
    Regul Toxicol Pharmacol; 2016 Nov; 81():128-135. PubMed ID: 27521610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of suspected illegal skin whitening cosmetics.
    Desmedt B; Van Hoeck E; Rogiers V; Courselle P; De Beer JO; De Paepe K; Deconinck E
    J Pharm Biomed Anal; 2014 Mar; 90():85-91. PubMed ID: 24334193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice.
    Mahé A; Perret JL; Ly F; Fall F; Rault JP; Dumont A
    Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):183-7. PubMed ID: 17023012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe.
    Desmedt B; Courselle P; De Beer JO; Rogiers V; Grosber M; Deconinck E; De Paepe K
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):943-50. PubMed ID: 26953335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of skin lightening agents in the United States and implications for public health.
    Liu Y; Krueger LD; Nguyen HP
    J Am Acad Dermatol; 2021 Dec; 85(6):1608-1610. PubMed ID: 33301804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.